Found: 9
Select item for more details and to access through your institution.
Molecular markers of head and neck squamous cell carcinoma: Promising signs in need of prospective evaluation.
- Published in:
- Head & Neck, 2006, v. 28, n. 3, p. 256, doi. 10.1002/hed.20326
- By:
- Publication type:
- Article
Patient-reported outcomes in terms of swallowing and quality of life after prophylactic versus reactive percutaneous endoscopic gastrostomy tube placement in advanced oropharyngeal cancer patients treated with definitive chemo-radiotherapy: Swall PEG study
- Published in:
- Trials, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s13063-022-06991-6
- By:
- Publication type:
- Article
Prophylactic gastrostomy in locally advanced head and neck cancer: results of a national survey among radiation oncologists.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Phase II trial evaluating the efficacy of sorafenib (BAY 43-9006) and correlating early fluorodeoxyglucose positron emission tomography-CT response to outcome in patients with recurrent and/or metastatic head and neck cancer.
- Published in:
- Head & Neck, 2016, v. 38, n. 3, p. 347, doi. 10.1002/hed.23898
- By:
- Publication type:
- Article
Meta‐Analysis on Induction Chemotherapy in Locally Advanced Nasopharyngeal Carcinoma.
- Published in:
- Oncologist, 2021, v. 26, n. 1, p. e130, doi. 10.1002/ONCO.13520
- By:
- Publication type:
- Article
Management of Head and Neck Cancer in Elderly Patients.
- Published in:
- Drugs & Aging, 2009, v. 26, n. 7, p. 571, doi. 10.2165/11316340-000000000-00000
- By:
- Publication type:
- Article
Safety and efficacy of nintedanib as second-line therapy for patients with differentiated or medullary thyroid cancer progressing after first-line therapy. A randomized phase II study of the EORTC Endocrine Task Force (protocol 1209-EnTF).
- Published in:
- Frontiers in Endocrinology, 2024, p. 1, doi. 10.3389/fendo.2024.1403687
- By:
- Publication type:
- Article
The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia: an expert survey in breast cancer and non-Hodgkin's lymphoma.
- Published in:
- 2010
- By:
- Publication type:
- journal article
The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia: an expert survey in breast cancer and non-Hodgkin¿s lymphoma.
- Published in:
- BMC Cancer, 2010, v. 10, p. 642, doi. 10.1186/1471-2407-10-642
- By:
- Publication type:
- Article